← All themes

GLP-1 & Obesity

GLP-1 medicines treat obesity and diabetes, and have grown into one of the largest drug categories ever launched. Their reach extends past medicine, because a change in how much people eat moves whole consumer industries.

92 stocks

Obesity Second-Order Effects

#	Name	Funds holding	Growth	Growth %	Fund value
1	1 Pfizer PFE $169B	2,324	-53	-2%	$142B
2	2 Amgen AMGN $238B	1,884	+19	+1%	$89.5B
3	3 Eli Lilly LLY $1.13T	1,525	+9	+0.6%	$83.3B
4	4 Becton Dickinson BDX $52.5B	1,403	+29	+2%	$58.5B
5	5 McKesson MCK $116B	839	-2	-0.2%	$21.8B
6	6 Conagra Brands CAG $6.82B	673	+11	+2%	$13.2B
7	7 Regeneron Pharmaceuticals REGN $82.4B	633	-25	-4%	$20.4B
8	8 Lamb Weston LW $7.47B	602	+3	+0.5%	$9.46B
9	9 Novo Nordisk NVO $174B	564	+5	+0.9%	$8.89B
10	10 AstraZeneca AZN $260B	556	+9	+2%	$20.5B
11	11 ResMed RMD $33.9B	528	+43	+9%	$13.1B
12	12 Teva Pharmaceutical Industries Limited TEVA $48.2B	428	-24	-5%	$4.07B
13	13 DaVita DVA $11.9B	416	+16	+4%	$7.21B
14	14 West Pharmaceutical WST $26.9B	406	+32	+9%	$9.57B
15	15 DELISTED CATALENT, INC. CTLT	298	+10	+3%	$7.09B
16	16 Medifast MED $135M	239	-12	-5%	$1.36B
17	17 DELISTED WW International WW	237	+25	+12%	$2.03B
18	ARNA 18 DELISTED Arena Pharmaceuticals Inc ARNA	230	+15	+7%	$1.96B
19	19 Herbalife HLF $1.52B	196	-21	-10%	$4.84B
20	20 Tootsie Roll Industries TR $2.89B	192	+5	+3%	$602M
21	21 Opko Health OPK $1.16B	187	-13	-7%	$308M
22	TWNK 22 DELISTED Hostess Brands, Inc. Class A Common Stock TWNK	176	+9	+5%	$1.96B
23	23 Accendra Health ACH $21.2M	175	+2	+1%	$322M
24	24 Fresenius Medical Care FMS $11.8B	161	-14	-8%	$286M
25	25 Inspire Medical Systems INSP $2B	155	+7	+5%	$1.33B